Factor XII Silencing Using siRNA Prevents Thrombus Formation in a Rat Model of Extracorporeal Life Support
Nao Umei(Nippon Medical School Hospital), Keith E. Cook, Atsuhiro Sakamoto(Nippon Medical School), Daria Strelkova(Carnegie Mellon University), Shingo Ichiba, Namit Chaudhary(Scripps Research Institute), Angela Lai, Jennifer Miller, Kalliope Roberts, Suji Shin(Yonsei University), Kathryn A. Whitehead(Carnegie Mellon University)
Cited by 6
Related Papers
Knocking down barriers: advances in siRNA delivery
|Nature Reviews Drug Discovery|2009|3.1k
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
|Nature Reviews Drug Discovery|2021|1.5k
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
|Nature Communications|2014|628
Managing diabetes with nanomedicine: challenges and opportunities
|Nature Reviews Drug Discovery|2014|608
The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs
|Journal of Controlled Release|2022|270